New Research On Owner Attitudes To Oral Medication Revealed
13 years ago
1689 views
Posted
23rd April, 2013 11h52
Dr Sarah Caney BVSc PhD DSAM (Feline) MRCVS questioned 111 owners for the research, which was supported by Dechra Veterinary Products and has been accepted for publication in the Journal of Feline Medicine and Surgery.
The survey revealed 89% of cat owners agreed with the statement that it 'was more important to me that the vet prescribes the most appropriate dose for my cat than that they provide me with an easy method of administering the medicine.'
Dr Caney said: “The survey has shown that cat owners are not a barrier to prescribing twice daily medication. Their overwhelming drive is to provide the best level of care that they can.
“From an owner perspective, the ideal anti-thyroid medication offers low doses and a variety of dosing strategies to ensure that each individual cat receives the dose they need and no more.”
The findings revealed that 'once daily treatment' was not ranked as the most important statement on dosing by any of the owners and that only 21% of owners who had experienced oral dosing of their cat described the process as either ‘tricky’ or ‘very difficult'.
Craig Sankey, Brand Manager for Felimazole® at Dechra Veterinary Products, said: “We are very pleased to have supported such an important piece of independent research relating to feline hyperthyroidism which challenges some of the assumptions made about owner needs.
“Ease of administering the medicine is not the overwhelming issue for owners of cats with hyperthyroidism – administering the correct dose is. In fact, 79 % of cat owners questioned were happy to give pills twice a day if necessary.”
To see the latest research in full, please visit www.dechra.co.uk/hyperthyroidismMore from
- 'Tax changes could land your practice with someone else's bills', warns vet founder
- Pet Health Clubs' fight for survival remains unresolved
- How a teenage James Herriot moved from clinic to boardroom
- Frustration to innovation: The shaping of transformative hiring platform
- Animus launches SkinBond Multi for enhanced wound care
2 days ago 